Naveen Pemmaraju
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Naveen Pemmaraju
Dec 24, 2023, 18:42 |
Insight
Naveen Pemmaraju: Important new paper led by Alex Bataller and Tapan Kadia
Naveen Pemmaraju shared on X/Twitter: "Important New paper just out in Blood Advances led by…
Dec 10, 2023, 20:01 |
Blog
Brittany Knick Ragon: If you are searching for a mentor, be sure to find one who brings light to those around them
Brittany Knick Ragon, Director of Hematology Operations, Department of Hematologic Oncology and Blood Disorders at…
Dec 9, 2023, 17:09 |
Blog
Naveen Pemmaraju: Honored to spend some great quality time with Richard Silver this evening at MPN Hero 2023
Naveen Pemmaraju, made the following post on X/Twitter: “ASH 23 Wow! What an evening. Honored…
Nov 30, 2023, 13:23 |
Blog
Naveen Pemmaraju: Honored to deliver lecture on BPDCN to our MD Anderson Cancer Center Heme/Onc Fellows!
Naveen Pemmaraju, made the following post on Twitter: "Honored to deliver lecture on Blastic Plasmacytoid…
Nov 17, 2023, 01:03 |
Blog
Naveen Pemmaraju: It warms my heart to welcome back our own Dr. Jayastu Senapati
Naveen Pemmaraju, posted the following on Twitter: "It warms my heart to welcome back our…
Nov 15, 2023, 17:56 |
Blog
Naveen Pemmaraju: Brand new paper CPX351 for patients with HR MDS and CMML s/p HMA
Quoting Naveen Pemmaraju on X/Twitter: "Brand new paper alert from our group led by Dr. Guillermo Montalban-Bravo…
Nov 11, 2023, 17:29 |
Positive
Naveen Pemmaraju: Thank you to all of our leukemia nurses- they are the best in the world!
Quoting Naveen Pemmaraju on X/Twitter: "Wonderful to be surrounded by so many outstanding colleagues in…
Nov 7, 2023, 02:51 |
Career
Naveen Pemmaraju: Dr Fadi Haddad is the Winner of Best Overall Abstract Award at the 15th International Congress on MPNs
Naveen Pemmaraju shared on Twitter: "Congratulations to Dr Fadi Haddad. Dr Fadi Haddad is the…
Oct 25, 2023, 17:36 |
Blog
Naveen Pemmaraju: Shout out to my fellow co-founding moderators for the successful first-in-person MPN Co&D meeting in Paris.
Naveen Pemmaraju shared on Twitter: "Shout out to my fellow co-founding moderators for the successful…
Oct 16, 2023, 18:19 |
Blog
BPDCN Updates and Progress in 2023 - Naveen Pemmaraju
On OncoDaily we are starting lectures from the experts through the BPDCN Global Network and…
Oct 11, 2023, 19:22 |
Blog
Naveen Pemmaraju: I was honored to Co-Chair the Inaugural in-person MPNCo and D Meeting October 2023 with Prof Ruben Mesa, MD and Prof Claire Harrison this week in Paris, France
Oct 4, 2023, 21:05 |
Blog
Naveen Pemmaraju: Honored to be invited to speak on Updates in BPDCN at Soho Italy in Rome, Italy this week!
Naveen Pemmaraju, made the following post on Twitter: "Honored to be invited to speak on Updates…
Oct 3, 2023, 18:28 |
Insight
Naveen Pemmaraju: Our group’s newest paper just out in Blood Cancer Journal led by Dr. Danielle Hammond.
Naveen Pemmaraju recently shared on Twitter: "Our group’s newest paper just out in Blood Cancer Journal…
Sep 25, 2023, 16:57 |
Insight
Lucia Masarova: Disease modification time in Polycythemia Vera is here!
Lucia Masarova, oncology specialist in Houston, TX, shared a post by Naveen Pemmaraju, on Twitter: "Disease…
Sep 18, 2023, 17:16 |
Blog
Vivek Subbiah: Exhilarating discussions with my dear friend and amazing colleague Naveen Pemmaraju.
Vivek Subbiah, Executive Director at MDACC Cancer Network, shared on X/Twitter: “Exhilarating discussions with my…
Sep 16, 2023, 19:08 |
Insight
Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared…
Sep 14, 2023, 17:52 |
Career
Naveen Pemmaraju: Deeply honored to share that I have been Promoted to Professor of Leukemia!
Naveen Pemmaraju recently shared on X/Twitter: "Deeply honored to share that I have been Promoted…
Sep 12, 2023, 17:40 |
Blog
11 Tweets from SOHO23 not to miss.
The Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) took place at…
Sep 8, 2023, 16:13 |
Societies
Naveen Pemmaraju: Delighted to be recognized by the Society of Hematologic Oncology for the Honorable Distinction Award
Naveen Pemmaraju, Leukemia Professor at the MD Anderson Cancer Center, shared on his Twitter account:…
Sep 7, 2023, 20:02 |
Societies
Naveen Pemmaraju: And SOHO23 week here in Houston Society of Hematology/Oncology begins!
Naveen Pemmaraju, Director of Department of Leukemia at MD Anderson Cancer Center, shared on Twitter:…
Sep 2, 2023, 19:00 |
Opinion
Naveen Pemmaraju: Please join us for a special episode of Heme Reports!
Naveen Pemmaraju, the Director of the Leukemia - Cancer Network at the MD Anderson Cancer Center,…
Aug 31, 2023, 19:04 |
Insight
Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.
Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center, recently…
Aug 31, 2023, 18:45 |
Career
Naveen Pemmaraju: Wonderful MDACC MPN team farewell luncheon today in honor of Mary Ann Richie, our leader for MPN research RN group, as she retires from MD Anderson Cancer Center!
Aug 30, 2023, 17:44 |
Opinion
Naveen Pemmaraju: Wonderful gathering of thought leaders, friends, colleagues in our myeloid leukemia field this weekend at the International Workshop on Acute Leukemias 2023 in San Diego!
Aug 28, 2023, 18:03 |
Blog
Naveen Pemmaraju: Make sure to follow on medtwitter our superstar brilliant hematology/oncology fellow MD Dr Hima Atluri.
Quoting Naveen Pemmaraju, the Executive Director of Cancer Medicine at MD Anderson Cancer Center, Texas,…
Aug 27, 2023, 19:01 |
Insight
Naveen Pemmaraju: New paper alert from our group led by our doctor Montalban Bravo and professor Garcia Manero.
Quoting Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center,…
Aug 20, 2023, 18:39 |
Blog
Naveen Pemmaraju: Delighted to spend a few moments with Nobel Laureate Dr. Jim Allison at our Faculty Awards ceremony.
Quoting Naveen Pemmaraju, Assistant Professor in the Department of Leukemia at Anderson Cancer Center, stated…
Aug 4, 2023, 18:24 |
Societies
Thanks Ann for all of your support and hard work and for your amazing 20 years of dedication to MD Anderson Cancer Center - Naveen Pemmaraju
Delighted to host my research protocol team for a lovely retirement luncheon for our MPN…
Jul 29, 2023, 18:50 |
Blog
All my appreciation for Naveen Pemmaraju for being a world leader in the field of BPDCN (yes 123 field !) and MPN - Nitin Jain
All my appreciation for Naveen Pemmaraju for being a world leader in the field of…
Jul 5, 2023, 05:38 |
Blog
15 years ago exactly to the day, I arrived in Houston TX - Naveen Pemmaraju
So grateful to MD Anderson Cancer Center !! 15 years ago exactly to the day, I arrived…
Jul 4, 2023, 10:34 |
Stories
Interim analysis of Pivekimab sunirine for patients with BPDCN - Naveen Pemmaraju
I recently had the honor of delivering an oral presentation on our international group’s clinical…
Jun 9, 2023, 02:54 |
Insight
The field of BPDCN is rapidly evolving - Hagop Kantarjian
The field of BPDCN is rapidly evolving. Our new article by Dr. Pemmaraju highlights the…
May 16, 2023, 10:39 |
Positive
If you have a #RareDisease it’s not rare to you! - Naveen Pemmaraju
A series of inspirational ideas & fantastic chats today in my quest to keep trying…
1
2
All:
133
Posts:
101 - 200
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube